{"id":"NCT03137784","sponsor":"Novartis Pharmaceuticals","briefTitle":"Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma","officialTitle":"A Multicenter, Randomized, Double-blind, Placebo-controlled 3-period Complete Cross-over Study to Assess the Bronchodilator Effects and Safety of Glycopyrronium Bromide (NVA237) (25 ug and 50 ug o.d.) in Asthma Patients.","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2017-05-04","primaryCompletion":"2017-12-29","completion":"2017-12-29","firstPosted":"2017-05-03","resultsPosted":"2019-01-16","lastUpdate":"2019-01-16"},"enrollment":148,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"NVA237 (glycopyrronium bromide)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1(NVA237 50 ug/NVA237 25 ug/placebo)","type":"OTHER"},{"label":"2(NVA237 50 ug/placebo/NVA237 25 ug)","type":"OTHER"},{"label":"3 (NVA237 25 ug/NVA237 50 ug/placebo)","type":"OTHER"},{"label":"4 (NVA237 25 ug/placebo/NVA237 50 ug)","type":"OTHER"},{"label":"5 (placebo/NVA237 50 ug/ NVA237 25 ug)","type":"OTHER"},{"label":"6 (placebo/ NVA237 25 ug/NVA237 50 ug)","type":"OTHER"}],"summary":"The purpose of this trial is to characterize the bronchodilator effects and safety of 25 ug and 50 ug o.d. NVA237 (glycopyrronium bromide) doses compared to placebo in asthma patients","primaryOutcome":{"measure":"Trough FEV1 After One Week of Treatment, Point Estimate","timeFrame":"Following 1 week of treatment","effectByArm":[{"arm":"NVA237 50 ug","deltaMin":2.392,"sd":0.0249},{"arm":"NVA237 25 ug","deltaMin":2.392,"sd":0.025},{"arm":"Placebo","deltaMin":2.303,"sd":0.0247}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":21,"countries":["United States","Belgium","Germany","Japan","Latvia","Lithuania"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":147},"commonTop":["Headache","Nasopharyngitis","Upper respiratory tract infection","Muscle strain","Dizziness"]}}